These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3766290)

  • 1. Piperonyl butoxide reduces salicylate-induced nephrotoxicity and covalent binding in male rats.
    Kyle ME; Kocsis JJ
    Adv Exp Med Biol; 1986; 197():717-26. PubMed ID: 3766290
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of mixed function oxidase induction and inhibition on salicylate-induced nephrotoxicity in male rats.
    Kyle ME; Kocsis JJ
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):241-9. PubMed ID: 3715872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of hexachlorobutadiene nephrotoxicity after piperonyl butoxide treatment.
    Davis ME
    Toxicology; 1984 Apr; 30(3):217-25. PubMed ID: 6710546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of ortho-bromophenol in the nephrotoxicity of bromobenzene in rats.
    Lau SS; Monks TJ; Greene KE; Gillette JR
    Toxicol Appl Pharmacol; 1984 Mar; 72(3):539-49. PubMed ID: 6710503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-treatment protection with piperonyl butoxide against acetaminophen hepatotoxicity is associated with changes in selective but not total covalent binding.
    Brady JT; Birge RB; Khairallah EA; Cohen SD
    Adv Exp Med Biol; 1991; 283():689-92. PubMed ID: 2069040
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity of precocene I in rats. Role of metabolic activation in vivo.
    Ravindranath V; Boyd MR; Jerina DM
    Biochem Pharmacol; 1987 Feb; 36(4):441-6. PubMed ID: 3827936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
    J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of salicylate by isolated kidney and liver mitochondria.
    Kyle ME; Kocsis JJ
    Chem Biol Interact; 1986 Oct; 59(3):325-35. PubMed ID: 3094966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nephrotoxicity of p-aminophenol. II. The effect of metabolic inhibitors and inducers.
    Calder IC; Yong AC; Woods RA; Crowe CA; Ham KN; Tange JD
    Chem Biol Interact; 1979 Oct; 27(2-3):245-54. PubMed ID: 498355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of a salicylate derivative bound to tissue proteins following administration of high doses of salicylate to rats.
    Hood W; Mendelson J; Villavicencio P; Grisolia S
    Physiol Chem Phys; 1973; 5(6):469-76. PubMed ID: 4786100
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of piperonyl butoxide on cephalosporin nephrotoxicity in the rabbit. An effect on cephaloridine transport.
    Tune BM; Kuo CH; Hook JB; Hsu CY; Fravert D
    J Pharmacol Exp Ther; 1983 Mar; 224(3):520-4. PubMed ID: 6827476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of renal necrosis induced by bromobenzene or chlorobenzene.
    Reid WD
    Exp Mol Pathol; 1973 Oct; 19(2):197-214. PubMed ID: 4754790
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroform toxicity in mice: correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules.
    Ilett KF; Reid WD; Sipes IG; Krishna G
    Exp Mol Pathol; 1973 Oct; 19(2):215-29. PubMed ID: 4754791
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity.
    Baliga R; Zhang Z; Baliga M; Ueda N; Shah SV
    Kidney Int; 1998 Nov; 54(5):1562-9. PubMed ID: 9844132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bioactivation inhibitors on covalent binding of 2-AAF to rat liver DNA in vivo and on hepatocytes cultures.
    Petit CR; Fournier PA; Lorenzon G; Burgat-Sacaze V; Rico AG
    Food Addit Contam; 1990; 7 Suppl 1():S66-8. PubMed ID: 2262042
    [No Abstract]   [Full Text] [Related]  

  • 16. S-(1,2,2-trichlorovinyl)-L-cysteine sulfoxide, a reactive metabolite of S-(1,2,2-Trichlorovinyl)-L-cysteine formed in rat liver and kidney microsomes, is a potent nephrotoxicant.
    Elfarra AA; Krause RJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1095-101. PubMed ID: 17347324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats.
    Dalvi RR; Dalvi PS
    Drug Chem Toxicol; 1991; 14(1-2):219-29. PubMed ID: 1889377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethyl maleate and protection by the microsomal enzyme inhibitor piperonyl butoxide.
    Kluwe WM; Hook JB
    Toxicol Appl Pharmacol; 1981 Jul; 59(3):457-66. PubMed ID: 7268770
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of piperonyl butoxide on hydroxylation of 2-acetylaminofluorene in hamster liver.
    Friedman MA; Woods S
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):623-30. PubMed ID: 897350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
    Boyd MR; Dutcher JS
    J Pharmacol Exp Ther; 1981 Mar; 216(3):640-6. PubMed ID: 7205642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.